Novo Nordisk CEO says experimental weight loss pill could become a best-in-class drug
[ad_1] Novo Nordisk CEO Lars Fruergaard Jørgensen on Friday said the company’s experimental weight loss pill, amycretin, could eventually become
Read More
Biotechnology
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
[ad_1] Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in
Read More
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
[ad_1] Cr | Istock | Getty Images Biotech company Viking Therapeutics has emerged as a strong potential entrant — or
Read More
CVS and Walgreens to start selling abortion pill mifepristone this month
[ad_1] A container holding boxes of Mifepristone, the first medication in a medical abortion, are prepared for patients at Alamo
Read More
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
[ad_1] Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21,
Read More
Enphase CEO says solar industry poised to rebound on falling interest rates and rising utility costs
[ad_1] Rafael Henrique | Lightrocket | Getty Images Enphase Energy sees light at the end of the tunnel this year
Read More
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11,
Read More
Eli Lilly results blow past estimates on strong Zepbound launch, surging Mounjaro revenue
[ad_1] Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020.
Read More
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
[ad_1] Boxes of Novo Nordisk’s weight-loss drug Wegovy in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters Danish drugmaker
Read More
Pfizer beats earnings estimates as declining Covid business performs better than expected
[ad_1] Pfizer CEO Albert Bourla talks during a press conference with European Commission President Ursula von der Leyen after a
Read More